[1]
|
Beckwitt, C.H., Clark, A.M., Ma, B., Whaley, D., Oltvai, Z.N. and Wells, A. (2018) Statins Attenuate Outgrowth of Breast Cancer Metastases. British Journal of Cancer, 119, 1094-1105. https://doi.org/10.1038/s41416-018-0267-7
|
[2]
|
Yousef, A. and Jad, A. (2017) Male Breast Cancer: Epidemiology and Risk Factors. Seminars in Oncology, 44, 267-272.
|
[3]
|
王芹, 李德俊, 吴玉萍. 内分泌治疗对绝经后乳腺癌患者血脂和骨骼健康的影响[J]. 中国当代医药, 2018, 25(29): 46-48.
|
[4]
|
于世英. 长期服用芳香化酶抑制剂的不良反应处理[C]//中国癌症基金会、中国抗癌协会肿瘤临床化疗专业委员会、中华医学会肿瘤学分会、全国肿瘤防治研究办公室、中国医学科学院肿瘤医院. 第三届中国肿瘤内科大会教育集暨论文集. 2009: 216-218.
|
[5]
|
Hershman, D.L., Till, C., Shen, S., et al. (2018) Association of Cardiovascular Risk Factors with Cardiac Events and Survival Outcomes among Patients with Breast Cancer Enrolled in SWOG Clinical Trials. Journal of Clinical Oncology, 36, 2710-2717. https://doi.org/10.1200/JCO.2017.77.4414
|
[6]
|
Mauriac, L., Keshaviah, A., Debled, M., Mouridsen, H., Forbes, J.F., Thürlimann, B., Paridaens, R., Monnier, A., Láng, I., Wardley, A., Nogaret, J.M., Gelber, R.D., Castiglione-Gertsch, M., Price, K.N., Coates, A.S., Smith, I., Viale, G., Rabaglio, M., Zabaznyi, N., Goldhirsch, A., BIG 1-98 Collaborative Group and International Breast Cancer Study Group (2007) Predictors of Early Relapse in Postmenopausal Women with Hormone Receptor-Positive Breast Cancer in the BIG 1-98 Trial. Annals of Oncology, 18, 859-867. https://doi.org/10.1093/annonc/mdm001
|
[7]
|
Smith, I., Yardley, D., Burris, H., et al. (2017) Comparative Efficacy and Safety of Adjuvant Letrozole versus Anastrozole in Postmenopausal Patients with Hormone Receptor-Positive, Node-Positive Early Breast Cancer: Final Results of the Randomized Phase III Femara versus Anastrozole Clinical Evaluation (FACE) Trial. Journal of Clinical Oncology, 35, 1041-1048.
|
[8]
|
Wang, X., Zhu, A.J., Wang, J.Y., et al. (2020) Steroidal Aromatase Inhibitors Have a More Favorable Effect on Lipid Profiles than Nonsteroidal Aromatase Inhibitors in Postmenopausal Women with Early Breast Cancer: A Prospective Cohort Study. Therapeutic Advances in Medical Oncology, 12. https://doi.org/10.1177/1758835920925991
|
[9]
|
Endo, A. (2008) A Gift from Nature: The Birth of the Statins. Nature Medicine, 14, 1050-1052.
https://doi.org/10.1038/nm1008-1050
|
[10]
|
Ahern, T.P., Lash, T.L., Damkier, P., Christiansen, P.M. and Cronin-Fenton, D.P. (2014) Statins and Breast Cancer Prognosis: Evidence and Opportunities. The Lancet Oncology, 15, e461-e468.
https://doi.org/10.1016/S1470-2045(14)70119-6
|
[11]
|
Bersot, T. (2011) Drug Therapy for Hypercholesterolemia and Dyslipidemia. In: Brunton, L.L., Chabner, B.A. and Knollman, B.C., Eds., Goodman & Gilman’s the Pharmacological Basis of Therapeutics, 12th Edition, McGraw-Hill, New York, 933-966.
|
[12]
|
Lamond, A.I. (2002) Review of: Molecular Biology of the Cell, 4th Edition. Nature, 417, 383.
https://doi.org/10.1038/417383a
|
[13]
|
Rosch, P.J. and McCully, K. (2013) Statin Use and Reduced Cancer-Related Mortality. The New England Journal of Medicine, 368, 576. https://doi.org/10.1056/NEJMc1214827
|
[14]
|
Niemi, M., Pasanen, M.K. and Neuvonen, P.J. (2011) Organic Anion Transporting Polypeptide 1B1: A Genetically Polymorphic Transporter of Major Importance for Hepatic Drug Uptake. Pharmacological Reviews, 63, 157-181.
https://doi.org/10.1124/pr.110.002857
|
[15]
|
孙忠实. 关于他汀类药若干争议的思考——从临床药理学角度诠释[J]. 中国医院用药评价与分析, 2014, 14(2): 97-99.
|
[16]
|
闫冰. 辛伐他汀联合紫杉醇靶向作用Hippo信号通路对乳腺癌干细胞的影响[D]: [硕士学位论文]. 大连: 大连医科大学, 2017.
|
[17]
|
Crescencio, M.E., Rodríguez, E., Páez, A., et al. (2009) Statins Inhibit the Proliferation and Induce Cell Death of Human Papilloma Virus Positive and Negative Cervical Cancer Cells. International Journal of Biomedical Science, 5, 411-420.
|
[18]
|
Beckwitt, C.H., Shiraha, K. and Wells, A. (2018) Lipophilic Statins Limit Cancer Cell Growth and Survival, via Involvement of Akt Signaling. PLoS ONE, 13, e0197422. https://doi.org/10.1371/journal.pone.0197422
|
[19]
|
Ghosh-Choudhury, N., Mandal, C.C., Ghosh-Choudhury, N. and Ghosh Choudhury, G. (2010) Simvastatin Induces Derepression of PTEN Expression via NFkappaB to Inhibit Breast Cancer Cell Growth. Cell Signal, 22, 749-758.
https://doi.org/10.1016/j.cellsig.2009.12.010
|
[20]
|
Gopalan, A., Yu, W., Sanders, B.G., et al. (2013) Simvastatin Inhibition of Mevalonate Pathway Induces Apoptosis in Human Breast Cancer Cells via Activation of jnk/chop/dr5 Signaling Pathway. Cancer Letters, 329, 9-16.
https://doi.org/10.1016/j.canlet.2012.08.031
|
[21]
|
Benn, M., Tybjærg-Hansen, A., Stender, S., Frikke-Schmidt, R. and Nordestgaard, B.G. (2011) Low-Density Lipoprotein Cholesterol and the Risk of Cancer: A Mendelian Randomization Study. Journal of the National Cancer Institute, 103, 508-519. https://doi.org/10.1093/jnci/djr008
|
[22]
|
Thurnher, M., Gruenbacher, G. and Nussbaumer, O. (2013) Regulation of Mevalonate Metabolism in Cancer and Immune Cells. Biochimica et Biophysica Acta, 1831, 1009-1015. https://doi.org/10.1016/j.bbalip.2013.03.003
|
[23]
|
Clendening, J.W., Pandyra, A., Boutros, P.C., et al. (2010) Dysregulation of the Mevalonate Pathway Promotes Transformation. Proceedings of the National Academy of Sciences of the United States of America, 107, 15051-15056.
https://doi.org/10.1073/pnas.0910258107
|
[24]
|
Borgquist, S., Jögi, A., Pontén, F., Rydén, L., Brennan, D.J. and Jirström, K. (2008) Prognostic Impact of Tumour-Specific HMG-CoA Reductase Expression in Primary Breast Cancer. Breast Cancer Research, 10, R79.
https://doi.org/10.1186/bcr2146
|
[25]
|
Nielsen, S.F., Nordestgaard, B.G. and Bojesen, S.E. (2012) Statin Use and Reduced Cancer-Related Mortality. The New England Journal of Medicine, 368, 576-577. https://doi.org/10.1056/NEJMoa1201735
|
[26]
|
Garwood, E.R., Kumar, A.S., Baehner, F.L., et al. (2010) Fluvastatin Reduces Proliferation and Increases Apoptosis in Women with High Grade Breast Cancer. Breast Cancer Research and Treatment, 119, 137-144.
https://doi.org/10.1007/s10549-009-0507-x
|
[27]
|
Bjarnadottir, O., Romero, Q., Bendahl, P.-O., et al. (2013) Targeting HMG-CoA Reductase with Statins in a Window-of-Opportunity Breast Cancer Trial. Breast Cancer Research and Treatment, 138, 499-508.
https://doi.org/10.1007/s10549-013-2473-6
|
[28]
|
Bjarnadottir, O., Kimburg, S., Johansson, I., et al. (2015) Global Transcriptional Changes Following Statin Treatment in Breast Cancer. Clinical Cancer Research, 21, 3402-3411. https://doi.org/10.1158/1078-0432.CCR-14-1403
|
[29]
|
Murtola, T.J., Visvanathan, K., Artama, M., Vainio, H. and Pukkala, E. (2014) Statin Use and Breast Cancer Survival: A Nationwide Cohort Study from Finland. PLoS ONE, 9, e110231. https://doi.org/10.1371/journal.pone.0110231
|
[30]
|
Cardwell, C.R., Hicks, B.M. and Hughes, C.M.L. (2015) Statin Use after Diagnosis of Breast Cancer and Survival: A Population-Based Cohort Study. Epidemiology, 26, 68-78. https://doi.org/10.1097/EDE.0000000000000189
|
[31]
|
Ahern, T.P., Pedersen, L., Tarp, M., et al. (2011) Statin Prescriptions and Breast Cancer Recurrence Risk: A Danish Nationwide Prospective Cohort Study. Journal of the National Cancer Institute, 103, 1461-1468.
https://doi.org/10.1093/jnci/djr291
|